Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00136266 · ClinicalTrials.gov registry record · Phase 3
Adherence With Iron Sprinkles Among High-Risk Infants
A Phase 3 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 3
- Development phase
- 128
- Enrollment target
NCT00136266 is a Phase 3 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 128 participants.
The verdict
NCT00136266, a Phase 3 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 128 participants
- Enrollment target
Study Summary
Compared with iron drops, iron sprinkles supplied for 3 months to high-risk children beginning at age 5-7 months will increase adherence and reduce the rates of anemia and iron deficiency.
Interventions
- DRUG Ferrous sulphate drops with vitamins A, D, and C
- DRUG Ferrous fumarate sprinkles with vitamins and minerals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2005-03 |
| Est. Completion | 2005-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00136266
The ClinicalTrials.gov registry entry for NCT00136266 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ferrous sulphate drops with vitamins A, D, and C is the first listed.
NCT00136266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00136266 about?
NCT00136266 is a clinical study titled "Adherence With Iron Sprinkles Among High-Risk Infants". Compared with iron drops, iron sprinkles supplied for 3 months to high-risk children beginning at age 5-7 months will increase adherence and reduce the rates of anemia and iron deficiency.
What is the current status of trial NCT00136266?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 128 participants. The study started on 2005-03. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00136266?
The interventions under investigation include: Ferrous sulphate drops with vitamins A, D, and C (DRUG), Ferrous fumarate sprinkles with vitamins and minerals (DRUG).
Who is sponsoring clinical trial NCT00136266?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.